Analysis of plasma proteome from cases of the different traditional Chinese medicine syndromes in patients with chronic hepatitis B

Journal of Pharmaceutical and Biomedical Analysis

Volumn 59, Issue 1, 2012, Pages 173-178

  Liu, Youping ^a   Liu, Peng ^a   Dai, Rongyang ^a   Wang, Jing ^a   Zheng, Yibin ^a   Shen, Jiyang ^a   Guo, Fanghong ^a   Wang, Leiqiong ^a   Li, Hong ^a   Wei, Mei ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis B; Plasma proteome; Traditional Chinese medical syndromes

Indexed keywords

C REACTIVE PROTEIN; HAPTOGLOBIN; IMMUNOGLOBULIN J CHAIN; PROTEOME; RETINOL BINDING PROTEIN; VITRONECTIN;

ADOLESCENT; ADULT; ARTICLE; CHRONIC DISEASE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOSTASIS; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SYNDROME; TRADITIONAL CHINESE MEDICINE SYNDROME; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

BLOOD PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B, CHRONIC; HUMANS; MEDICINE, CHINESE TRADITIONAL; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SYNDROME; YANG DEFICIENCY; YIN DEFICIENCY;

EID: 82255179212     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.10.002     Document Type: Article

References (30)

1. Chan E., Tan M., Xin J., Sudarsanam S., Johnson D.E. Interactions between traditional chinese medicines and western therapeutics. Curr. Opin. Drug Discov. Dev. 2010, 13:50-65.
2. Dai W., Wei C., Kong H., Jia Z., Han J., Zhang F., Wu Z., Gu Y., Chen S., Gu Q., Lu X., Wu Y., Xu G. Effect of the traditional Chinese medicine tongxinluo on endothelial dysfunction rats studied by using urinary metabonomics based on liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2011, 56:86-92.
3. Lu A., Jiang M., Zhang C., Chan K. An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. J. Ethnopharmacol. 2011, [Epub ahead of print].
4. Yang H.Z., Zhao J.A., Dai M., Li Y.W., Wang Y.Z., Guan W.B., Xie H.P. Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant. World J. Gastroenterol. 2005, 11:2004-2008.
5. Tang L.L., Sheng J.F., Xu C.H., Liu K.Z. Clinical and experimental effectiveness of Astragali compound in the treatment of chronic viral hepatitis B. J. Int. Med. Res. 2009, 37:662-667.
6. Stickel F., Schuppan D. Herbal medicine in the treatment of liver diseases. Digest. Liver Dis. 2007, 39:293-304.
7. Yu J.H., Shi J.P., Wu J., Li X.O., Guo J.C., Xun Y.H., Zhao C., Jin J., Xu A.F., Lou G.Q. Efficacy and safety of lamivudine plus adefovir combination therapy and entecavir monotherapy for chronic hepatitis B patients. Zhonghua Gan Zang Bing Za Zhi 2011, 19:88-92.
8. Wang X., Sun H., Zhang A., Sun W., Wang P., Wang Z. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J. Pharm. Biomed. Anal. 2011, 55:859-868.
9. Chinese Medicine The Web That Has No Weaver 2000, 2nd ed. T. Kaptchuk (Ed.).
10. Li S., Zhang N.B., Li Z.H. Decision tree diagnostic model of Gan-dan damp-heat syndrome and Gan-stangnancy pi-deficiency syndrome in patients with chronic hepatitis B. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009, 29:993-996.
11. Chu Y.G., Shi J., Hu Y.H., Wu H.Q., Liu G.J., Hu C.J., Li Y.Z., Li Y., Chen Z.J., He Q. Serum proteomes of hypertension patients with abundant phlegm-dampness. Zhong Xi Yi Jie He Xue Bao 2009, 7:629-635.
12. Desiderio C., Rossetti D.V., Iavarone F., Messana I., Castagnola M. Capillary electrophoresis-mass spectrometry: recent trends in clinical proteomics. J. Pharm. Biomed. Anal. 2010, 53:1161-1169.
13. Rodland K.D. Protemics and cancer diagnosis: the potential of mass spectrometry. Clin. Biochem. 2004, 37:579-583.
14. Altenbach S.B., Tanaka C.K., Hurkman W.J., Whitehand L.C., Vensel W.H., Dupont F.M. Differential effects of a post-anthesis fertilizer regimen on the wheat flour proteome determined by quantitative 2-DE. Proteome Sci. 2011, 9:46.
15. The standards of TCM differential syndromes of viral hepatitis. Defined in December 1991 by Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association.
16. Gou Y.J. Experimental Technique for Protein Electrophoresis 2005, Science Press, Beijing. 2nd ed.
17. Görg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000, 21:1037-1053.
18. Li T.W., Zheng B.R., Huang Z.X., Lin Q., Zhao L.K., Liao Z.T., Zhao J.J., Lin Z.M., Gu J.R. Screening disease-associated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study. Chin. Med. J. (Engl.) 2010, 123:537-543.
19. Campos-Sandoval J.A., Redondo C., Kinsella G.K., Pal A., Jones G., Eyre G.S., Hirst S.C., Findlay J.B. Fenretinide derivatives act as disrupters of interactions of serum retinol binding protein (sRBP) with transthyretin and the sRBP receptor. J. Med. Chem. 2011, 54:4378-4387.
20. Shu H., Zhang S., Kang X., Li S., Qin X., Sun C., Lu H., Liu Y. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases. Acta Biochim. Biophys. Sin. (Shanghai) 2011, 43:528-534.
21. Carter K., Worwood M. Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int. J. Lab. Hematol. 2007, 29:92-110.
22. Qin X., Xie L., Chen X.Y., Dai Z., Cui J.F., Kang X.N., Peng K., Shu H., Li S., Liu Y.K. Proteomic analysis of hepatitis B virus-infected human liver tissues. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2007, 21:349-351.
23. Zhang G.L., Wu Q.K., Lin Q. Study on correlation between TCM syndrome type and pathological changes of liver tissue in 260 patients with chronic hepatitis B. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007, 27:613-615.
24. Mi Y.Q., Zheng S.W., Zhang H. Relationship between HBV-DNA in peripheral blood mononuclear cells and syndrome types of TCM in chronic hepatitis B patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007, 27:296-299.
25. Koenig W., Khuseyinova N., Baumert J., Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study 1984-1998. Clin. Chem. 2008, 54:335-342.
26. Liu S.L., Cheng C.C., Chang C.C., Mai F.D., Wang C.C., Lee S.C., Ho A.S., Chen L.Y., Chang J. Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein. J. Biomed. Sci. 2011, 18:52.
27. Kushner I. The phenomenon of the acute phase response. Ann. N.Y. Acad. Sci. 1982, 389:39-48.
28. Riaz S., Alam S.S., Akhtar M.W. Proteomic identification of human serum biomarkers in diabetes mellitus type 2. J. Pharm. Biomed. Anal. 2010, 51:1103-1107.
29. Brandtzaeg P., Prydz H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 1984, 311:71-73.
30. Brandtzaeg P., Johansen F.E. Mucosal B cells: phenotypic characteristics transcriptional regulation, and homing properties. Immunol. Rev. 2005, 206:32-63.